By Liz Warren-Pederson
Xenia Kachur, a Ph.D. student in biomedical engineering, brought home a $50,000 prize when she topped the 2011 Tulane Business Plan Competition in April, beating out competition from schools including MIT and Stanford.
Her venture, Pathostat, LLC, aims to commercialize a novel, patent-pending medical device technology for use during cancer surgery which enables the surgical oncology team to precisely excise and assess cancerous tissue.
“We were extremely impressed by both the quantity and quality of the plans submitted in this year’s competition,” said Christopher Williams, president of Tulane Entrepreneurs Association. “It gives us reassurance that the principles of conscious capitalism are continuing to spread throughout the global business community. The plans advancing to the Final Round represent the best ideas that our generation has to offer, and the Tulane Entrepreneurs Association is proud to be associated with ventures of this caliber.”
The competition required participants to submit executive summaries, from which qualifying finalists were invited to submit 30-page business plans. Three finalists were selected to present to industry professionals, who assessed the ventures based on viability and social impact.
Kachur is also part of a four-person team behind the McGuire venture project Acubens Biotech. The venture identifies, licenses, and commercializes cancer-related patents currently held in isolated “silos” at universities and research institutions.
She graduated from Northern Arizona University with a BS in biomedical microbiology and a minor in chemistry.